Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

December 18, 2023

https://www.globenewswire.com/news-release/2023/12/18/2797675/0/en/Blue-Water-Biotech-Acquires-Proteomedix-as-Part-of-Transformation-to-Commercial-Stage-Oncology-Company-Announces-Name-Change-to-Onconetix.html

CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (Nasdaq:BWV) (“BWB” or the “Company”) today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology company (the “Transaction”), and introduced a new name for the combined Company: Onconetix, Inc. The Transaction reflects a transformation of the business to one focused on the research, development and commercialization of proprietary science and technologies for therapeutics, diagnostics and services for the treatment of cancer.

Read more at globenewswire.com

Related news for (BWV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.